Ligand Pharma Inc (Class B) Live Stock Price Today, Share Analysis and Chart

Name: Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B: Is Infosys Ltd. worth buying?
Item: Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
Rating: 2.449333375
Author: Trendlyne DVM scores

Turnaround Potential

about

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Lig...

298.36 8.29 (2.86%)

82.54% Gain from 52W Low

124.9K

XNAS Volume

XNAS 22 Sep, 2026 3:41 PM (EDT)

Medium Financial Strength

50.0 / 100

Mid Valuation

35.7 / 100

Technically Moderately Bullish

60.3 / 100

Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM

343

1Yr Price target upside is 15%

11 analysts

Ligand Pharma Inc (Class B) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ligand Pharma Inc (Class B) Live Stock Price Today, Share Analysis and Chart

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Lig...

82.54% Gain from 52W Low

SWOT Analysis

Ligand Pharma Inc (Class B) Live Price Chart

Ligand Pharma Inc (Class B) Live Price Chart